surpass-cvot tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM | Med Journal Club Diabetes Distilled: SURPASS-CVOT – Tirzepatide
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29


01774-X/asset/3608bfb3-6329-4132-95b7-cc3434437493/main.assets/gr2_lrg.jpg)









:max_bytes(150000):strip_icc()/Health-GLP1-pill-vs-shot-137cf589ddca421bb0aef5c5d7aec64a.png)














